Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1994 Dec;161(6):579–584.

Antibiotic therapy for ocular infection.

R W Snyder 1, D B Glasser 1
PMCID: PMC1022739  PMID: 7856158

Abstract

Infections of the eye can rapidly damage important functional structures and lead to permanent vision loss or blindness. Broad-spectrum antibiotics should be administered to the appropriate site of infection as soon as a diagnosis is made. Topical drops are preferred for corneal and conjunctival infections. Intravitreal antibiotics, and possibly subconjunctival and parenteral antibiotics, are preferred for endophthalmitis. Parenteral antibiotics are recommended for infection in deep adnexal structures. We review specific aspects of antibiotic therapy for ocular and periocular infection.

Full text

PDF
579

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALLEN H. F., MANGIARACINE A. B. BACTERIAL ENDOPHTHALMITIS AFTER CATARACT EXTRACTION. A STUDY OF 22 INFECTIONS IN 20,000 OPERATIONS. Arch Ophthalmol. 1964 Oct;72:454–462. doi: 10.1001/archopht.1964.00970020454003. [DOI] [PubMed] [Google Scholar]
  2. ARONSTAM R. H. PITFALLS OF PROPHYLAXIS; ALTERATION OF POSTOPERATIVE INFECTION BY PENICILLIN-STREPTOMYCIN. Am J Ophthalmol. 1964 Feb;57:312–315. [PubMed] [Google Scholar]
  3. Allen H. F., Mangiaracine A. B. Bacterial endophthalmitis after cataract extraction. II. Incidence in 36,000 consecutive operations with special reference to preoperative topical antibiotics. Arch Ophthalmol. 1974 Jan;91(1):3–7. doi: 10.1001/archopht.1974.03900060007002. [DOI] [PubMed] [Google Scholar]
  4. Barza M., Peckman C., Baum J. Transscleral iontophoresis of cefazolin, ticarcillin, and gentamicin in the rabbit. Ophthalmology. 1986 Jan;93(1):133–139. doi: 10.1016/s0161-6420(86)33780-1. [DOI] [PubMed] [Google Scholar]
  5. Baum J. Treatment of bacterial ulcers of the cornea in the rabbit: a comparison of administration by eye drops and subconjunctival injections. Trans Am Ophthalmol Soc. 1982;80:369–390. [PMC free article] [PubMed] [Google Scholar]
  6. Benson H. Permeability of the cornea to topically applied drugs. Arch Ophthalmol. 1974 Apr;91(4):313–327. doi: 10.1001/archopht.1974.03900060323017. [DOI] [PubMed] [Google Scholar]
  7. Betts R. F., Valenti W. M., Chapman S. W., Chonmaitree T., Mowrer G., Pincus P., Messner M., Robertson R. Five-year surveillance of aminoglycoside usage in a university hospital. Ann Intern Med. 1984 Feb;100(2):219–222. doi: 10.7326/0003-4819-100-2-219. [DOI] [PubMed] [Google Scholar]
  8. Binder P. S., Rasmussen D. M., Gordon M. Keratoconjunctivitis and soft contact lens solutions. Arch Ophthalmol. 1981 Jan;99(1):87–90. doi: 10.1001/archopht.1981.03930010089009. [DOI] [PubMed] [Google Scholar]
  9. Campochiaro P. A., Conway B. P. Aminoglycoside toxicity--a survey of retinal specialists. Implications for ocular use. Arch Ophthalmol. 1991 Jul;109(7):946–950. doi: 10.1001/archopht.1991.01080070058035. [DOI] [PubMed] [Google Scholar]
  10. Chalkley T. H., Shock D. An evaluation of prophylactic subconjunctival antibiotic injection in cataract surgery. Am J Ophthalmol. 1967 Dec;64(6):1084–1087. doi: 10.1016/0002-9394(67)93060-7. [DOI] [PubMed] [Google Scholar]
  11. D'Amico D. J., Caspers-Velu L., Libert J., Shanks E., Schrooyen M., Hanninen L. A., Kenyon K. R. Comparative toxicity of intravitreal aminoglycoside antibiotics. Am J Ophthalmol. 1985 Aug 15;100(2):264–275. doi: 10.1016/0002-9394(85)90792-5. [DOI] [PubMed] [Google Scholar]
  12. Davis S. D., Sarff L. D., Hyndiuk R. A. Antibiotic therapy of experimental Pseudomonas keratitis in guinea pigs. Arch Ophthalmol. 1977 Sep;95(9):1638–1643. doi: 10.1001/archopht.1977.04450090160016. [DOI] [PubMed] [Google Scholar]
  13. Davis S. D., Sarff L. D., Hyndiuk R. A. Bacteriologic cure of experimental Pseudomonas keratitis. Invest Ophthalmol Vis Sci. 1978 Sep;17(9):916–918. [PubMed] [Google Scholar]
  14. Davis S. D., Sarff L. D., Hyndiuk R. A. Comparison of therapeutic routes in experimental Pseudomonas keratitis. Am J Ophthalmol. 1979 May;87(5):710–716. doi: 10.1016/0002-9394(79)90309-x. [DOI] [PubMed] [Google Scholar]
  15. Davis S. D., Sarff L. D., Hyndiuk R. A. Topical tobramycin therapy of experimental Pseudomonas keratitis: an evaluation of some factors that potentially enhance efficacy. Arch Ophthalmol. 1978 Jan;96(1):123–125. doi: 10.1001/archopht.1978.03910050079020. [DOI] [PubMed] [Google Scholar]
  16. Diamond J. G. Intraocular management of endophthalmitis. A systematic approach. Arch Ophthalmol. 1981 Jan;99(1):96–99. doi: 10.1001/archopht.1981.03930010098011. [DOI] [PubMed] [Google Scholar]
  17. Duncan I. B., Cheung E. Y., Haldane E. V., Jackson F. L., McNaughton R. D., Morisset R. A., Noble M. A., Rennie R. P., Ronald A. R., Smith J. A. Resistance to aminoglycoside antibiotics of gram-negative bacilli isolated in Canadian hospitals. Can Med Assoc J. 1981 May 1;124(9):1165–1167. [PMC free article] [PubMed] [Google Scholar]
  18. Elliott R. D., Katz H. R. Inhibition of pseudophakic endophthalmitis in a rabbit model. Ophthalmic Surg. 1987 Jul;18(7):538–541. [PubMed] [Google Scholar]
  19. Fisher J. P., Civiletto S. E., Forster R. K. Toxicity, efficacy, and clearance of intravitreally injected of cefazolin. Arch Ophthalmol. 1982 Apr;100(4):650–652. doi: 10.1001/archopht.1982.01030030652026. [DOI] [PubMed] [Google Scholar]
  20. Forster R. K., Abbott R. L., Gelender H. Management of infectious endophthalmitis. Ophthalmology. 1980 Apr;87(4):313–319. doi: 10.1016/s0161-6420(80)35241-x. [DOI] [PubMed] [Google Scholar]
  21. Gibson J. R. Trimethoprim-polymyxin B ophthalmic solution in the treatment of presumptive bacterial conjunctivitis--a multicentre trial of its efficacy versus neomycin-polymyxin B-gramicidin and chloramphenicol ophthalmic solutions. J Antimicrob Chemother. 1983 Mar;11(3):217–221. doi: 10.1093/jac/11.3.217. [DOI] [PubMed] [Google Scholar]
  22. Gigliotti F., Williams W. T., Hayden F. G., Hendley J. O., Benjamin J., Dickens M., Gleason C., Perriello V. A., Wood J. Etiology of acute conjunctivitis in children. J Pediatr. 1981 Apr;98(4):531–536. doi: 10.1016/s0022-3476(81)80754-8. [DOI] [PubMed] [Google Scholar]
  23. Glasser D. B., Gardner S., Ellis J. G., Pettit T. H. Loading doses and extended dosing intervals in topical gentamicin therapy. Am J Ophthalmol. 1985 Mar 15;99(3):329–332. doi: 10.1016/0002-9394(85)90364-2. [DOI] [PubMed] [Google Scholar]
  24. Hughes L., Maurice D. M. A fresh look at iontophoresis. Arch Ophthalmol. 1984 Dec;102(12):1825–1829. doi: 10.1001/archopht.1984.01040031483028. [DOI] [PubMed] [Google Scholar]
  25. Hyndiuk R. A. Experimental Pseudomonas keratitis. Trans Am Ophthalmol Soc. 1981;79:541–624. [PMC free article] [PubMed] [Google Scholar]
  26. Javitt J. C., Vitale S., Canner J. K., Street D. A., Krakauer H., McBean A. M., Sommer A. National outcomes of cataract extraction. Endophthalmitis following inpatient surgery. Arch Ophthalmol. 1991 Aug;109(8):1085–1089. doi: 10.1001/archopht.1991.01080080045025. [DOI] [PubMed] [Google Scholar]
  27. Jones D. B. Initial therapy of suspected microbial corneal ulcers. II. Specific antibiotic therapy based on corneal smears. Surv Ophthalmol. 1979 Sep-Oct;24(2):97, 105-16. doi: 10.1016/0039-6257(79)90128-0. [DOI] [PubMed] [Google Scholar]
  28. Leibowitz H. M. Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis. Am J Ophthalmol. 1991 Oct;112(4 Suppl):29S–33S. [PubMed] [Google Scholar]
  29. Leibowitz H. M. Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol. 1991 Oct;112(4 Suppl):34S–47S. [PubMed] [Google Scholar]
  30. Lemp M. A., Ralph R. A. Rapid development of band keratopathy in dry eyes. Am J Ophthalmol. 1977 May;83(5):657–659. doi: 10.1016/0002-9394(77)90131-3. [DOI] [PubMed] [Google Scholar]
  31. McDermott M. L., Tran T. D., Cowden J. W., Buggé C. J. Corneal stromal penetration of topical ciprofloxacin in humans. Ophthalmology. 1993 Feb;100(2):197–200. doi: 10.1016/s0161-6420(13)31672-8. [DOI] [PubMed] [Google Scholar]
  32. Menikoff J. A., Speaker M. G., Marmor M., Raskin E. M. A case-control study of risk factors for postoperative endophthalmitis. Ophthalmology. 1991 Dec;98(12):1761–1768. doi: 10.1016/s0161-6420(91)32053-0. [DOI] [PubMed] [Google Scholar]
  33. Moellering R. C., Jr, Wennersten C., Kunz L. J., Poitras J. W. Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria. Am J Med. 1977 Jun;62(6):873–881. doi: 10.1016/0002-9343(77)90655-6. [DOI] [PubMed] [Google Scholar]
  34. Mondino B. J., Groden L. R. Conjunctival hyperemia and corneal infiltrates with chemically disinfected soft contact lenses. Arch Ophthalmol. 1980 Oct;98(10):1767–1770. doi: 10.1001/archopht.1980.01020040619005. [DOI] [PubMed] [Google Scholar]
  35. Petroutsos G., Guimaraes R., Giraud J., Pouliquen Y. Antibiotics and corneal epithelial wound healing. Arch Ophthalmol. 1983 Nov;101(11):1775–1778. doi: 10.1001/archopht.1983.01040020777023. [DOI] [PubMed] [Google Scholar]
  36. Peyman G. A., Vastine D. W., Raichand M. Experimental aspects and their clinical application. Ophthalmology. 1978 Apr;85(4):374–385. doi: 10.1016/s0161-6420(78)35659-1. [DOI] [PubMed] [Google Scholar]
  37. Pfister R. R., Burstein N. The effects of ophthalmic drugs, vehicles, and preservatives on corneal epithelium: a scanning electron microscope study. Invest Ophthalmol. 1976 Apr;15(4):246–259. [PubMed] [Google Scholar]
  38. Ristuccia A. M., Cunha B. A. The aminoglycosides. Med Clin North Am. 1982 Jan;66(1):303–312. doi: 10.1016/s0025-7125(16)31462-6. [DOI] [PubMed] [Google Scholar]
  39. Shell J. W. Pharmacokinetics of topically applied ophthalmic drugs. Surv Ophthalmol. 1982 Jan-Feb;26(4):207–218. doi: 10.1016/0039-6257(82)90081-9. [DOI] [PubMed] [Google Scholar]
  40. Soukiasian S. H., Foster C. S., Niles J. L., Raizman M. B. Diagnostic value of anti-neutrophil cytoplasmic antibodies in scleritis associated with Wegener's granulomatosis. Ophthalmology. 1992 Jan;99(1):125–132. doi: 10.1016/s0161-6420(92)32027-5. [DOI] [PubMed] [Google Scholar]
  41. Speaker M. G., Menikoff J. A. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991 Dec;98(12):1769–1775. doi: 10.1016/s0161-6420(91)32052-9. [DOI] [PubMed] [Google Scholar]
  42. Spizziri L. J. Stromal corneal changes due to preserved saline solution used in soft contact lens wear: report of a case. Ann Ophthalmol. 1981 Nov;13(11):1277–1278. [PubMed] [Google Scholar]
  43. Stern G. A., Schemmer G. B., Farber R. D., Gorovoy M. S. Effect of topical antibiotic solutions on corneal epithelial wound healing. Arch Ophthalmol. 1983 Apr;101(4):644–647. doi: 10.1001/archopht.1983.01040010644025. [DOI] [PubMed] [Google Scholar]
  44. Tonjum A. M. Effects of benzalkonium chloride upon the corneal epithelium studied with scanning electron microscopy. Acta Ophthalmol (Copenh) 1975 Jun;53(3):358–366. doi: 10.1111/j.1755-3768.1975.tb01167.x. [DOI] [PubMed] [Google Scholar]
  45. Wilson L. A., McNatt J., Reitschel R. Delayed hypersensitivity to thimerosal in soft contact lens wearers. Ophthalmology. 1981 Aug;88(8):804–809. doi: 10.1016/s0161-6420(81)34945-8. [DOI] [PubMed] [Google Scholar]
  46. Yannis R. A., Rissing J. P., Buxton T. B., Shockley R. K. Multistrain comparison of three antimicrobial prophylaxis regimens in experimental postoperative Pseudomonas endophthalmitis. Am J Ophthalmol. 1985 Sep 15;100(3):404–407. doi: 10.1016/0002-9394(85)90501-x. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES